Skip to content

Orthofix Medical Inc. OFIX Payments Of Merger Related Costs Financing Activities

Payments Of Merger Related Costs Financing Activities at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$196.7M+1.6%
Gross profit$139.5M+14.7%
Operating income-$14.4M+70.5%
Net income-$20.9M+60.6%
EPS (diluted)-$0.52+61.5%

Balance sheet

See full
Cash & equivalents$120.3M+108%
Total debt$237.5M+32.3%
Total equity$435.2M-5.0%
Total assets$886.6M+7.7%

Cash flow

See full
Operating cash flow-$17.6M+4.2%
CapEx$10.7M+58.3%
Free cash flow-$28.3M-12.5%

Valuation

See full
Market cap$376.33M-7.1%
Enterprise value$493.54M-6.3%
P/S0.5×0.0×

Profitability

See full
Gross margin70.7%+3.6pp
Operating margin-5.8%-2.1pp
Net margin-7.3%-2.7pp
FCF margin-9.3%-1.7pp

Returns & leverage

See full
Return on equity-13.4%-4.6pp
Debt / equity0.5×+0.2×
Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities.

The official record: Orthofix Medical Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s payments of merger related costs financing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Orthofix Medical Inc.'s payments of merger related costs financing activities?
Orthofix Medical Inc. (OFIX) reported payments of merger related costs financing activities of $6.72M in Q4 2023.
What does payments of merger related costs financing activities mean?
This metric represents cash outflows associated with the integration, legal, advisory, and administrative costs incurred during business combinations or corporate acquisitions. It reflects the capital intensity of inorganic growth strategies and the immediate financial impact of consolidating acquired entities. Investors monitor this to assess the total cost of acquisition beyond the initial purchase price.